FDA Inspection
Puremedy Inc.Puremedy Inc. – FDA Inspection, Jul 26, 2024
Record Details
This FDA Inspection record concerns Puremedy Inc., with an inspection on July 26, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 15d79331-184b-4974-add4-67cc2662e874
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1245199
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
9- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.125(a)Strict control not exercised over labeling issued
- 21 CFR 211.160(a)Lab controls established, including changes
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.166(c)(1)Homeopathic drugs, assessment of stability
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.84(d)(1)Identity Testing of Each Component
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Puremedy Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 12, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Puremedy Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.